{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:35:51Z","timestamp":1793385351046,"version":"4.5.0"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamacardio.2020.4939","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T11:30:53Z","timestamp":1603884653000},"page":"179","source":"Crossref","is-referenced-by-count":102,"title":["Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease"],"prefix":"10.1001","volume":"6","author":[{"given":"Ezimamaka","family":"Ajufo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby R.","family":"Ayers","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Vigen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Division of Cardiology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag H.","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Division of Cardiology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Rohatgi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Division of Cardiology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Division of Cardiology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khera","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Division of Cardiology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9678","key":"hoi200073r1","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"hoi200073r2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11883-015-0555-0","article-title":"Aspirin for the primary prevention of cardiovascular disease: in need of clarity.","volume":"18","author":"Miedema","year":"2016","journal-title":"Curr Atheroscler Rep"},{"issue":"16","key":"hoi200073r3","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMe1812000","article-title":"Should aspirin be used for primary prevention in the post-statin era?","volume":"379","author":"Ridker","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"hoi200073r4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"10152","key":"hoi200073r5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"hoi200073r6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus.","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"hoi200073r7","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"hoi200073r8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/CIRCOUTCOMES.113.000690","article-title":"Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis.","volume":"7","author":"Miedema","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"19","key":"hoi200073r9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.119.045010","article-title":"Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA Study (Multi-Ethnic Study of Atherosclerosis).","volume":"141","author":"Cainzos-Achirica","year":"2020","journal-title":"Circulation"},{"issue":"22","key":"hoi200073r10","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"hoi200073r11","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jacc.2004.07.047","article-title":"Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.","volume":"44","author":"Deo","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"hoi200073r12","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jacc.2004.05.069","article-title":"African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study.","volume":"44","author":"Jain","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi200073r13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1532-429X-16-33","article-title":"Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: the Dallas heart study.","volume":"16","author":"Maroules","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6","key":"hoi200073r14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.7326\/M18-2808","article-title":"Predicting bleeding risk to guide aspirin use for the primary prevention of cardiovascular disease.","volume":"170","author":"Selak","year":"2019","journal-title":"Ann Intern Med"},{"issue":"13","key":"hoi200073r15","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups.","volume":"358","author":"Detrano","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"hoi200073r16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis.","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"hoi200073r17","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2018.8194","article-title":"Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy.","volume":"319","author":"Selak","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"hoi200073r18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.amjcard.2019.07.016","article-title":"Usefulness of Coronary Artery Calcium to Identify Adults of Sufficiently High Risk for Atherothrombotic Cardiovascular Events to Consider Low-Dose Rivaroxaban Thromboprophylaxis (from MESA).","volume":"124","author":"Arps","year":"2019","journal-title":"Am J Cardiol"},{"issue":"21","key":"hoi200073r19","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes.","volume":"307","author":"De Berardis","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"hoi200073r20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.7326\/M15-2112","article-title":"Bleeding risks with aspirin use for primary prevention in adults: a systematic review for the U.S. preventive services task force.","volume":"164","author":"Whitlock","year":"2016","journal-title":"Ann Intern Med"},{"issue":"24","key":"hoi200073r21","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"hoi200073r23","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","article-title":"Aspirin for primary prevention of cardiovascular events.","volume":"73","author":"Abdelaziz","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi200073r24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archinternmed.2011.628","article-title":"Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.","volume":"172","author":"Seshasai","year":"2012","journal-title":"Arch Intern Med"},{"key":"hoi200073r22","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcz049","article-title":"The influence of the baseline 10-year atherosclerotic cardiovascular disease risk on cardiovascular outcomes with aspirin for primary prevention: a meta-regression analysis.","volume-title":"Eur Hear J","author":"Mahmoud","year":"2020"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2772390\/jamacardiology_ajufo_2020_oi_200073_1612387634.54678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:29:13Z","timestamp":1669339753000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2772390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2020.4939","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}